Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza ALynn Bimler, Silke Paust, Sydney L. Ronzulli et al.|Journal of Virology|2020Cited by 18
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutationsTeha Kim, Silke Paust, Amber Y. Song et al.|Science Advances|2025Cited by 8
A Low-Dose Triple Antibody Cocktail Against the Ectodomain of the Matrix Protein 2 of Influenza A Is A Universally Effective and Viral Escape Mutant Resistant Therapeutic AgentTeha Kim, Silke Paust, Lynn Bimler et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Correction for Bimler et al., “Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A”Lynn Bimler, Silke Paust, Sydney L. Ronzulli et al.|Journal of Virology|2022Cited by 0
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral functionKayla Frank, Silke Paust, Himani Sharma et al.|Cell Reports|2026Cited by 0